ArticleBMC biomedical engineering2019
An automatic nuclei segmentation method based on deep convolutional neural networks for histopathology images.
Article in BMC biomedical engineering, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed.
- Image-based analysis of lymphoma cell heterogeneity: Comparative study of CRYO and FFPE techniques.Journal of pathology informatics · 2026Article
- A Real-Time Cell Image Segmentation Method Based on Multi-Scale Feature Fusion.Bioengineering (Basel, Switzerland) · 2025Article
- Clustering cell nuclei on microgrooves for disease diagnosis using deep learning.Scientific reports · 2025Article
- Comparative Study of Cell Nuclei Segmentation Based on Computational and Handcrafted Features Using Machine Learning Algorithms.Diagnostics (Basel, Switzerland) · 2025Article
- Improving generalization capability of deep learning-based nuclei instance segmentation by non-deterministic train time and deterministic test time stain normalization.Computational and structural biotechnology journal · 2024Article
- Artificial intelligence: illuminating the depths of the tumor microenvironment.Journal of translational medicine · 2024Review
- CD20Heliyon · 2024Article
- Automatic Myeloblast Segmentation in Acute Myeloid Leukemia Images based on Adversarial Feature Learning.Computer methods and programs in biomedicine · 2024Article
- Histological classification of canine and feline lymphoma using a modular approach based on deep learning and advanced image processing.Scientific reports · 2023Article
- Breast Cancer Histopathological Images Segmentation Using Deep Learning.Sensors (Basel, Switzerland) · 2023Article
- Evaluation of cell segmentation methods without reference segmentations.Molecular biology of the cell · 2023Article
- Article
- A survey on recent trends in deep learning for nucleus segmentation from histopathology images.Evolving systems · 2023Review
- Different approaches to Imaging Mass Cytometry data analysis.Bioinformatics advances · 2023Review
- Convolutional Blur Attention Network for Cell Nuclei Segmentation.Sensors (Basel, Switzerland) · 2022Article
- Clinical Significance of a CD3/CD8-Based Immunoscore in Neuroblastoma Patients Using Digital Pathology.Frontiers in immunology · 2022Article
- Breast histopathological image analysis using image processing techniques for diagnostic puposes: A methodological review.Journal of medical systems · 2021Review
- AI in spotting high-risk characteristics of medical imaging and molecular pathology.Precision clinical medicine · 2021Review
- Article
- Deep Learning Approaches and Applications in Toxicologic Histopathology: Current Status and Future Perspectives.Journal of pathology informatics · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSince nuclei segmentation in histopathology images can provide key information for identifying the presence or stage of a disease, the images need to be assessed carefully. However, color variation in histopathology images, and various structures of nuclei are two major obstacles in accurately segmenting and analyzing histopathology images. Several machine learning methods heavily rely on hand-crafted features which have limitations due to manual thresholding.
resultsTo obtain robust results, deep learning based methods have been proposed. Deep convolutional neural networks (DCNN) used for automatically extracting features from raw image data have been proven to achieve great performance. Inspired by such achievements, we propose a nuclei segmentation method based on DCNNs. To normalize the color of histopathology images, we use a deep convolutional Gaussian mixture color normalization model which is able to cluster pixels while considering the structures of nuclei. To segment nuclei, we use Mask R-CNN which achieves state-of-the-art object segmentation performance in the field of computer vision. In addition, we perform multiple inference as a post-processing step to boost segmentation performance. We evaluate our segmentation method on two different datasets. The first dataset consists of histopathology images of various organ while the other consists histopathology images of the same organ. Performance of our segmentation method is measured in various experimental setups at the object-level and the pixel-level. In addition, we compare the performance of our method with that of existing state-of-the-art methods. The experimental results show that our nuclei segmentation method outperforms the existing methods.
conclusionsWe propose a nuclei segmentation method based on DCNNs for histopathology images. The proposed method which uses Mask R-CNN with color normalization and multiple inference post-processing provides robust nuclei segmentation results. Our method also can facilitate downstream nuclei morphological analyses as it provides high-quality features extracted from histopathology images.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.